Total Funding
42
12
Total FundingPrivate Equity raised
Growth Score
-5 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
723483
Molecular Health offers software solutions for evidence-based healthcare decision support and smarter drug development.
- Stephan Brock: Chief Technology Officer
Friedrich Bohlen: Chief Executive OfficerPast Role: LION Bioscience AG, Co-Founder & CEO
About the Company
Since 2004, Molecular Health has stood for transforming big data into precise, actionable decisions for all stakeholders in healthcare. Their cloud-based Dataome® technology platform analyzes the molecular and clinical data of individual patients against the world’s medical, biological, and pharmacological knowledge, to drive more precise
diagnostic, therapeutic, and drug safety decisions.
Their products are used across the healthcare sector, as more precise ways of practicing medicine impact the treatment of patients and the development of effective drugs, requiring ever more complex levels of data interpretation.
The company is financed by Dievini Hopp BioTech, an investment vehicle of former SAP CEO and founder Dietmar Hopp.
